Home » Authors » Aaron Lorenzo

Articles by Aaron Lorenzo

Xechem Buys Ceptor, Adds Size To Niche Drug Pipeline

Dec. 31, 2003

By Aaron Lorenzo

Arena Raises $35M Through Sale Of Preferred Convertible Shares

Dec. 30, 2003

By Aaron Lorenzo

Arena Raises $35M Through Sale Of Preferred Convertible Shares

Dec. 30, 2003

By Aaron Lorenzo

Inspire Gets Approvable Letter Asking For More Diquafosol Data

Dec. 23, 2003

By Aaron Lorenzo

Inspire Gets Approvable Letter Asking For More Diquafosol Data

Dec. 23, 2003

By Aaron Lorenzo

Pharmacopeia Plans To Divide Drug Discovery, Software Units

Dec. 22, 2003

By Aaron Lorenzo

Pharmacopeia Plans To Divide Drug Discovery, Software Units

Dec. 22, 2003

By Aaron Lorenzo

Sequenom, P&G Enter $30M Agreement For Osteoporosis

Dec. 19, 2003

By Aaron Lorenzo

Sequenom, P&G Enter $30M Agreement For Osteoporosis

Dec. 19, 2003

By Aaron Lorenzo

FDA Receives Supplemental NDA For Fuzeon From Trimeris, Roche

Dec. 17, 2003

By Aaron Lorenzo

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...